 Monika Headrick
Concepts (536)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 42 | 2023 | 836 | 5.550 |
Why?
| | Erythrocytes | 28 | 2024 | 591 | 5.050 |
Why?
| | Blood Proteins | 11 | 2020 | 231 | 3.850 |
Why?
| | Proteome | 20 | 2022 | 339 | 3.810 |
Why?
| | Blood Preservation | 16 | 2024 | 263 | 3.560 |
Why?
| | Erythrocyte Transfusion | 9 | 2023 | 189 | 2.850 |
Why?
| | Hemolysis | 12 | 2024 | 146 | 2.570 |
Why?
| | Fibrinolysis | 7 | 2022 | 158 | 2.030 |
Why?
| | Extracellular Matrix Proteins | 5 | 2021 | 127 | 1.850 |
Why?
| | Extracellular Matrix | 8 | 2023 | 436 | 1.730 |
Why?
| | Mass Spectrometry | 14 | 2019 | 633 | 1.530 |
Why?
| | Chromatography, Liquid | 7 | 2017 | 347 | 1.390 |
Why?
| | Blood Coagulation Disorders | 5 | 2023 | 197 | 1.330 |
Why?
| | Mesentery | 3 | 2014 | 53 | 1.310 |
Why?
| | Anemia, Sickle Cell | 4 | 2023 | 215 | 1.300 |
Why?
| | Wounds and Injuries | 6 | 2022 | 749 | 1.240 |
Why?
| | beta-Thalassemia | 4 | 2023 | 23 | 1.170 |
Why?
| | Tandem Mass Spectrometry | 7 | 2016 | 412 | 1.140 |
Why?
| | Tissue Plasminogen Activator | 6 | 2023 | 225 | 1.080 |
Why?
| | Lymph | 3 | 2018 | 40 | 1.080 |
Why?
| | Plasma | 4 | 2017 | 211 | 1.050 |
Why?
| | Blood Coagulation | 6 | 2023 | 218 | 1.010 |
Why?
| | Tissue Scaffolds | 2 | 2019 | 179 | 0.980 |
Why?
| | Extracellular Vesicles | 5 | 2023 | 83 | 0.960 |
Why?
| | Blood Platelets | 4 | 2015 | 351 | 0.950 |
Why?
| | Plateletpheresis | 2 | 2015 | 25 | 0.950 |
Why?
| | Survival of Motor Neuron 1 Protein | 2 | 2016 | 8 | 0.940 |
Why?
| | Lipopolysaccharides | 10 | 2022 | 823 | 0.900 |
Why?
| | Reticulocytes | 1 | 2023 | 16 | 0.890 |
Why?
| | Isoantibodies | 1 | 2023 | 57 | 0.850 |
Why?
| | Blood Donors | 5 | 2024 | 89 | 0.850 |
Why?
| | Oxidative Stress | 10 | 2022 | 1076 | 0.780 |
Why?
| | Metabolome | 4 | 2021 | 282 | 0.770 |
Why?
| | Humans | 81 | 2024 | 114705 | 0.760 |
Why?
| | Arginine | 1 | 2022 | 238 | 0.750 |
Why?
| | Animals | 38 | 2023 | 31709 | 0.730 |
Why?
| | Sex Characteristics | 3 | 2015 | 641 | 0.700 |
Why?
| | Shock, Hemorrhagic | 5 | 2023 | 199 | 0.690 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 4 | 2017 | 318 | 0.670 |
Why?
| | Hypoxia | 7 | 2023 | 958 | 0.670 |
Why?
| | Lipid Metabolism | 2 | 2017 | 444 | 0.670 |
Why?
| | Acellular Dermis | 1 | 2019 | 12 | 0.670 |
Why?
| | Metabolomics | 7 | 2024 | 521 | 0.650 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 338 | 0.620 |
Why?
| | Thrombelastography | 7 | 2023 | 180 | 0.620 |
Why?
| | Coronavirus Infections | 2 | 2020 | 330 | 0.620 |
Why?
| | Complement System Proteins | 2 | 2021 | 283 | 0.610 |
Why?
| | Tissue Engineering | 3 | 2019 | 364 | 0.610 |
Why?
| | Mice | 19 | 2023 | 14872 | 0.610 |
Why?
| | Hemoglobins | 4 | 2022 | 315 | 0.610 |
Why?
| | Hydroxylamine | 1 | 2017 | 8 | 0.590 |
Why?
| | Hydrogels | 4 | 2023 | 573 | 0.580 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2017 | 83 | 0.570 |
Why?
| | Interleukin-6 | 2 | 2020 | 676 | 0.550 |
Why?
| | Mycophenolic Acid | 1 | 2017 | 77 | 0.540 |
Why?
| | Nucleotides | 1 | 2017 | 112 | 0.530 |
Why?
| | Pandemics | 3 | 2023 | 1320 | 0.530 |
Why?
| | Coiled Bodies | 1 | 2016 | 7 | 0.520 |
Why?
| | Campylobacter jejuni | 3 | 2011 | 11 | 0.520 |
Why?
| | Microtubule-Associated Proteins | 2 | 2021 | 174 | 0.510 |
Why?
| | Myocardium | 3 | 2022 | 913 | 0.500 |
Why?
| | Hydroxylysine | 1 | 2015 | 4 | 0.500 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 2 | 2020 | 13 | 0.490 |
Why?
| | Extinction, Biological | 1 | 2015 | 29 | 0.480 |
Why?
| | Oxidation-Reduction | 7 | 2021 | 923 | 0.480 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2016 | 139 | 0.470 |
Why?
| | Nanoparticles | 2 | 2022 | 313 | 0.450 |
Why?
| | Neutrophils | 4 | 2022 | 1176 | 0.450 |
Why?
| | Lymph Nodes | 2 | 2018 | 419 | 0.440 |
Why?
| | Proteolysis | 2 | 2017 | 142 | 0.430 |
Why?
| | Erythrocyte Deformability | 1 | 2022 | 12 | 0.420 |
Why?
| | Immunosuppressive Agents | 1 | 2017 | 646 | 0.420 |
Why?
| | Collagen | 1 | 2015 | 415 | 0.420 |
Why?
| | Thrombophilia | 1 | 2023 | 67 | 0.420 |
Why?
| | Paxillin | 1 | 2022 | 10 | 0.420 |
Why?
| | Repressor Proteins | 1 | 2016 | 366 | 0.420 |
Why?
| | Male | 28 | 2023 | 55607 | 0.410 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2012 | 35 | 0.410 |
Why?
| | Biomarkers | 8 | 2022 | 3408 | 0.410 |
Why?
| | Oxygen | 3 | 2022 | 854 | 0.410 |
Why?
| | Valosin Containing Protein | 1 | 2022 | 6 | 0.400 |
Why?
| | Cell Proliferation | 6 | 2022 | 2187 | 0.400 |
Why?
| | Intestinal Mucosa | 1 | 2017 | 532 | 0.400 |
Why?
| | Superoxides | 2 | 2022 | 214 | 0.400 |
Why?
| | Glycolysis | 4 | 2022 | 227 | 0.400 |
Why?
| | O Antigens | 3 | 2006 | 8 | 0.390 |
Why?
| | Cytoplasmic Dyneins | 1 | 2021 | 7 | 0.390 |
Why?
| | Female | 27 | 2023 | 59521 | 0.390 |
Why?
| | Autoimmune Diseases of the Nervous System | 1 | 2022 | 21 | 0.390 |
Why?
| | Carnitine | 1 | 2022 | 62 | 0.380 |
Why?
| | Nervous System Malformations | 1 | 2022 | 34 | 0.380 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 6 | 2021 | 797 | 0.370 |
Why?
| | Plesiomonas | 3 | 2006 | 3 | 0.370 |
Why?
| | B7-H1 Antigen | 1 | 2022 | 139 | 0.370 |
Why?
| | Gangliosides | 1 | 2011 | 18 | 0.370 |
Why?
| | Endosomes | 1 | 2021 | 124 | 0.360 |
Why?
| | Breast Neoplasms | 3 | 2022 | 1862 | 0.350 |
Why?
| | Glioblastoma | 1 | 2022 | 253 | 0.340 |
Why?
| | Biological Products | 1 | 2022 | 166 | 0.330 |
Why?
| | Thrombosis | 1 | 2022 | 298 | 0.330 |
Why?
| | Proteins | 2 | 2023 | 908 | 0.330 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2019 | 43 | 0.330 |
Why?
| | Resuscitation | 3 | 2017 | 252 | 0.330 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 1 | 2019 | 40 | 0.320 |
Why?
| | Adult | 18 | 2023 | 30553 | 0.320 |
Why?
| | Molecular Sequence Data | 9 | 2015 | 2785 | 0.320 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 367 | 0.320 |
Why?
| | Androgen Antagonists | 1 | 2019 | 69 | 0.320 |
Why?
| | Protein Processing, Post-Translational | 3 | 2019 | 399 | 0.320 |
Why?
| | Cellular Reprogramming | 2 | 2021 | 84 | 0.310 |
Why?
| | Cells, Cultured | 7 | 2021 | 3886 | 0.310 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 1140 | 0.310 |
Why?
| | Brain Injuries, Traumatic | 1 | 2023 | 303 | 0.310 |
Why?
| | Energy Metabolism | 3 | 2022 | 731 | 0.300 |
Why?
| | Middle Aged | 14 | 2023 | 26738 | 0.300 |
Why?
| | Androgens | 1 | 2019 | 167 | 0.300 |
Why?
| | Hematopoietic Stem Cells | 1 | 2021 | 343 | 0.290 |
Why?
| | Inflammation | 7 | 2023 | 2480 | 0.290 |
Why?
| | Lymphokines | 1 | 2017 | 111 | 0.290 |
Why?
| | Transcriptome | 3 | 2022 | 726 | 0.280 |
Why?
| | Cell Line, Tumor | 7 | 2022 | 2711 | 0.280 |
Why?
| | Ketones | 1 | 2017 | 44 | 0.280 |
Why?
| | Leukocyte Reduction Procedures | 2 | 2018 | 25 | 0.280 |
Why?
| | Asparagine | 2 | 2018 | 29 | 0.280 |
Why?
| | Rats | 7 | 2023 | 4958 | 0.280 |
Why?
| | alpha 1-Antitrypsin | 2 | 2022 | 103 | 0.270 |
Why?
| | Chondrogenesis | 2 | 2020 | 79 | 0.270 |
Why?
| | Hemorrhage | 4 | 2023 | 620 | 0.270 |
Why?
| | Apocrine Glands | 1 | 2016 | 4 | 0.270 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2022 | 486 | 0.270 |
Why?
| | Aldehydes | 1 | 2017 | 138 | 0.270 |
Why?
| | Xanthine Dehydrogenase | 1 | 2016 | 25 | 0.270 |
Why?
| | Time Factors | 6 | 2018 | 6116 | 0.270 |
Why?
| | Lung | 3 | 2015 | 3561 | 0.270 |
Why?
| | Molecular Chaperones | 1 | 2017 | 157 | 0.260 |
Why?
| | Glycolipids | 1 | 2016 | 35 | 0.260 |
Why?
| | Neutrophil Activation | 2 | 2018 | 94 | 0.260 |
Why?
| | Injury Severity Score | 2 | 2018 | 499 | 0.250 |
Why?
| | Milk | 1 | 2016 | 124 | 0.250 |
Why?
| | Magnetic Resonance Spectroscopy | 4 | 2017 | 473 | 0.250 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2019 | 638 | 0.250 |
Why?
| | Multiple Organ Failure | 2 | 2022 | 146 | 0.240 |
Why?
| | Electrophoresis, Capillary | 3 | 2008 | 21 | 0.240 |
Why?
| | Brain Neoplasms | 1 | 2022 | 979 | 0.240 |
Why?
| | Protein Conformation | 1 | 2017 | 805 | 0.230 |
Why?
| | Glycoproteins | 1 | 2016 | 304 | 0.230 |
Why?
| | Bacteria | 2 | 2022 | 725 | 0.230 |
Why?
| | Cell Membrane | 2 | 2016 | 680 | 0.230 |
Why?
| | Chromosomal Proteins, Non-Histone | 2 | 2015 | 100 | 0.230 |
Why?
| | Ubiquitination | 2 | 2016 | 86 | 0.230 |
Why?
| | Amino Acid Sequence | 4 | 2015 | 1982 | 0.230 |
Why?
| | Interferons | 2 | 2022 | 151 | 0.230 |
Why?
| | Blood Group Antigens | 1 | 2023 | 14 | 0.220 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2023 | 11 | 0.220 |
Why?
| | Reactive Oxygen Species | 5 | 2022 | 531 | 0.220 |
Why?
| | Epitopes | 3 | 2008 | 435 | 0.220 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2022 | 270 | 0.220 |
Why?
| | Glucose | 3 | 2018 | 897 | 0.220 |
Why?
| | Haemophilus influenzae | 2 | 2008 | 48 | 0.220 |
Why?
| | Swine | 3 | 2023 | 700 | 0.220 |
Why?
| | Birth Injuries | 1 | 2023 | 11 | 0.220 |
Why?
| | Proteasome Endopeptidase Complex | 3 | 2022 | 133 | 0.220 |
Why?
| | Hypocalcemia | 1 | 2023 | 31 | 0.220 |
Why?
| | Sphingosine | 1 | 2023 | 33 | 0.210 |
Why?
| | Acute-Phase Proteins | 2 | 2014 | 64 | 0.210 |
Why?
| | Pelvic Organ Prolapse | 1 | 2023 | 39 | 0.210 |
Why?
| | Solubility | 2 | 2017 | 223 | 0.210 |
Why?
| | DNA Modification Methylases | 1 | 2022 | 14 | 0.210 |
Why?
| | Serpins | 1 | 2022 | 25 | 0.210 |
Why?
| | Carbohydrate Sequence | 7 | 2008 | 23 | 0.210 |
Why?
| | Platelet Transfusion | 1 | 2023 | 64 | 0.210 |
Why?
| | Arginase | 1 | 2022 | 27 | 0.210 |
Why?
| | Lysophospholipids | 1 | 2023 | 65 | 0.210 |
Why?
| | Signal Transduction | 6 | 2022 | 4516 | 0.200 |
Why?
| | Glucosephosphate Dehydrogenase | 1 | 2022 | 37 | 0.200 |
Why?
| | Case-Control Studies | 5 | 2022 | 3003 | 0.200 |
Why?
| | Protein Transport | 2 | 2021 | 395 | 0.200 |
Why?
| | Erythroblasts | 1 | 2022 | 12 | 0.200 |
Why?
| | Blood Banks | 2 | 2021 | 40 | 0.200 |
Why?
| | Rejuvenation | 2 | 2021 | 14 | 0.200 |
Why?
| | Macrophages | 4 | 2023 | 1263 | 0.200 |
Why?
| | Citrulline | 1 | 2022 | 40 | 0.200 |
Why?
| | Endothelial Cells | 3 | 2023 | 687 | 0.200 |
Why?
| | beta-Globins | 1 | 2022 | 10 | 0.200 |
Why?
| | Fibrinolysin | 1 | 2022 | 15 | 0.190 |
Why?
| | Isoaspartic Acid | 1 | 2021 | 3 | 0.190 |
Why?
| | Protein D-Aspartate-L-Isoaspartate Methyltransferase | 1 | 2021 | 5 | 0.190 |
Why?
| | Anion Exchange Protein 1, Erythrocyte | 1 | 2021 | 22 | 0.190 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2015 | 333 | 0.190 |
Why?
| | Blood | 1 | 2022 | 96 | 0.190 |
Why?
| | Cell Cycle Proteins | 3 | 2022 | 551 | 0.190 |
Why?
| | Receptors, Glucocorticoid | 1 | 2022 | 130 | 0.190 |
Why?
| | Methods | 2 | 2018 | 58 | 0.190 |
Why?
| | Hypertension, Pulmonary | 2 | 2022 | 1729 | 0.190 |
Why?
| | Saccharomyces cerevisiae | 2 | 2015 | 476 | 0.180 |
Why?
| | Virulence Factors | 1 | 2022 | 139 | 0.180 |
Why?
| | Erythrocyte Membrane | 1 | 2021 | 50 | 0.180 |
Why?
| | Seroconversion | 1 | 2021 | 45 | 0.180 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2020 | 27 | 0.180 |
Why?
| | Aging | 3 | 2021 | 1618 | 0.180 |
Why?
| | Betacoronavirus | 2 | 2020 | 250 | 0.180 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2022 | 249 | 0.180 |
Why?
| | Thrombin | 3 | 2023 | 139 | 0.180 |
Why?
| | Databases, Genetic | 1 | 2021 | 206 | 0.170 |
Why?
| | Mice, Inbred C57BL | 4 | 2021 | 4694 | 0.170 |
Why?
| | Cell Line | 5 | 2018 | 2637 | 0.170 |
Why?
| | Membrane Lipids | 1 | 2020 | 87 | 0.170 |
Why?
| | Lipid A | 2 | 2008 | 28 | 0.170 |
Why?
| | Antibodies, Bacterial | 2 | 2008 | 119 | 0.170 |
Why?
| | Spermatogenesis | 1 | 2020 | 52 | 0.170 |
Why?
| | Altitude | 1 | 2023 | 432 | 0.170 |
Why?
| | Protein Stability | 2 | 2017 | 157 | 0.170 |
Why?
| | Parabiosis | 1 | 2019 | 12 | 0.160 |
Why?
| | Dyneins | 1 | 2019 | 29 | 0.160 |
Why?
| | Oligosaccharides | 3 | 2006 | 46 | 0.160 |
Why?
| | Nitric Oxide | 2 | 2022 | 823 | 0.160 |
Why?
| | Adenosine Triphosphatases | 2 | 2022 | 153 | 0.160 |
Why?
| | Semen Analysis | 2 | 2020 | 10 | 0.160 |
Why?
| | Mitochondria | 2 | 2022 | 747 | 0.160 |
Why?
| | Fertility | 1 | 2020 | 130 | 0.160 |
Why?
| | Mice, Knockout | 2 | 2023 | 2570 | 0.160 |
Why?
| | Metabolic Networks and Pathways | 3 | 2022 | 168 | 0.160 |
Why?
| | Infertility, Male | 2 | 2020 | 59 | 0.160 |
Why?
| | Myocytes, Cardiac | 1 | 2022 | 449 | 0.150 |
Why?
| | Aspartic Acid | 1 | 2018 | 77 | 0.150 |
Why?
| | Proteus penneri | 1 | 2008 | 1 | 0.150 |
Why?
| | Spermatozoa | 2 | 2020 | 84 | 0.150 |
Why?
| | Sodium Chloride | 2 | 2015 | 136 | 0.150 |
Why?
| | Basophils | 1 | 2018 | 64 | 0.150 |
Why?
| | Omalizumab | 1 | 2018 | 45 | 0.150 |
Why?
| | Protons | 2 | 2007 | 73 | 0.150 |
Why?
| | Acetylation | 4 | 2019 | 211 | 0.150 |
Why?
| | Blood Transfusion | 3 | 2022 | 293 | 0.150 |
Why?
| | Anti-Allergic Agents | 1 | 2018 | 41 | 0.150 |
Why?
| | Hypoxanthine | 1 | 2017 | 9 | 0.150 |
Why?
| | Urticaria | 1 | 2018 | 36 | 0.150 |
Why?
| | Trastuzumab | 2 | 2022 | 89 | 0.140 |
Why?
| | Fibrinolytic Agents | 2 | 2022 | 234 | 0.140 |
Why?
| | Microtubules | 1 | 2019 | 237 | 0.140 |
Why?
| | Fibroblasts | 1 | 2021 | 838 | 0.140 |
Why?
| | Freeze Drying | 1 | 2017 | 75 | 0.140 |
Why?
| | Immune Sera | 2 | 2004 | 79 | 0.140 |
Why?
| | Basigin | 1 | 2017 | 25 | 0.140 |
Why?
| | Chromatography, Affinity | 1 | 2017 | 80 | 0.140 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2018 | 511 | 0.140 |
Why?
| | Preoperative Period | 1 | 2017 | 103 | 0.140 |
Why?
| | Gene Expression Profiling | 3 | 2021 | 1518 | 0.140 |
Why?
| | DNA | 2 | 2022 | 1352 | 0.140 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 8 | 0.130 |
Why?
| | Purines | 1 | 2017 | 159 | 0.130 |
Why?
| | Epithelial Cells | 2 | 2016 | 951 | 0.130 |
Why?
| | Isotope Labeling | 1 | 2017 | 69 | 0.130 |
Why?
| | Pancreas | 1 | 2018 | 276 | 0.130 |
Why?
| | Apoptosis | 3 | 2022 | 2363 | 0.130 |
Why?
| | Mammals | 3 | 2022 | 244 | 0.130 |
Why?
| | Rats, Sprague-Dawley | 3 | 2018 | 2218 | 0.130 |
Why?
| | Healthy Volunteers | 1 | 2017 | 197 | 0.130 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 53 | 0.130 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 107 | 0.130 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2016 | 18 | 0.130 |
Why?
| | Workflow | 1 | 2017 | 133 | 0.130 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 138 | 0.130 |
Why?
| | Receptor, PAR-2 | 1 | 2015 | 8 | 0.130 |
Why?
| | Myocardial Infarction | 1 | 2022 | 927 | 0.130 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2015 | 30 | 0.130 |
Why?
| | Bison | 1 | 2015 | 6 | 0.120 |
Why?
| | Plasminogen | 1 | 2015 | 33 | 0.120 |
Why?
| | Bacterial Proteins | 4 | 2022 | 736 | 0.120 |
Why?
| | Chemical Fractionation | 1 | 2015 | 28 | 0.120 |
Why?
| | Gelsolin | 1 | 2014 | 9 | 0.120 |
Why?
| | Hafnia alvei | 1 | 2004 | 1 | 0.120 |
Why?
| | Serine Proteases | 1 | 2014 | 14 | 0.120 |
Why?
| | Microcirculation | 1 | 2015 | 135 | 0.120 |
Why?
| | Glycosylation | 1 | 2015 | 130 | 0.120 |
Why?
| | Kallikreins | 1 | 2014 | 30 | 0.120 |
Why?
| | Glutamine | 1 | 2015 | 91 | 0.120 |
Why?
| | Rats, Inbred F344 | 1 | 2015 | 241 | 0.120 |
Why?
| | Aquaporin 4 | 1 | 2015 | 87 | 0.120 |
Why?
| | Muscle, Skeletal | 2 | 2023 | 1473 | 0.120 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 3 | 2007 | 162 | 0.120 |
Why?
| | Blood Component Transfusion | 1 | 2015 | 78 | 0.120 |
Why?
| | Skull | 1 | 2015 | 119 | 0.110 |
Why?
| | Prognosis | 2 | 2022 | 3330 | 0.110 |
Why?
| | Complex Mixtures | 1 | 2014 | 11 | 0.110 |
Why?
| | Organ Size | 1 | 2015 | 436 | 0.110 |
Why?
| | Peptide Hydrolases | 1 | 2014 | 104 | 0.110 |
Why?
| | Neural Stem Cells | 1 | 2015 | 115 | 0.110 |
Why?
| | Homeostasis | 2 | 2022 | 573 | 0.110 |
Why?
| | Pilot Projects | 1 | 2018 | 1373 | 0.110 |
Why?
| | Blotting, Western | 2 | 2011 | 1147 | 0.110 |
Why?
| | High-Throughput Screening Assays | 1 | 2015 | 123 | 0.110 |
Why?
| | Neuromyelitis Optica | 1 | 2015 | 115 | 0.110 |
Why?
| | Glycoconjugates | 1 | 2003 | 7 | 0.110 |
Why?
| | Tetanus Toxoid | 1 | 2003 | 37 | 0.110 |
Why?
| | Stem Cell Niche | 1 | 2013 | 42 | 0.110 |
Why?
| | Cluster Analysis | 1 | 2014 | 455 | 0.110 |
Why?
| | Thromboplastin | 1 | 2023 | 71 | 0.110 |
Why?
| | Young Adult | 4 | 2021 | 10471 | 0.110 |
Why?
| | Central Nervous System | 1 | 2015 | 235 | 0.110 |
Why?
| | Survival of Motor Neuron 2 Protein | 1 | 2012 | 3 | 0.100 |
Why?
| | Protein-Arginine N-Methyltransferases | 1 | 2022 | 16 | 0.100 |
Why?
| | Cumulus Cells | 1 | 2012 | 6 | 0.100 |
Why?
| | Pyruvates | 1 | 2022 | 20 | 0.100 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 445 | 0.100 |
Why?
| | Inosine | 1 | 2022 | 11 | 0.100 |
Why?
| | Spinal Muscular Atrophies of Childhood | 1 | 2012 | 14 | 0.100 |
Why?
| | Ubiquitin-Specific Peptidase 7 | 1 | 2022 | 3 | 0.100 |
Why?
| | Leukocyte Count | 1 | 2013 | 293 | 0.100 |
Why?
| | Lymphoid Tissue | 1 | 2022 | 62 | 0.100 |
Why?
| | Cardiac Surgical Procedures | 1 | 2017 | 414 | 0.100 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2017 | 176 | 0.100 |
Why?
| | Endotoxins | 1 | 2003 | 211 | 0.100 |
Why?
| | Solute Carrier Family 22 Member 5 | 1 | 2022 | 4 | 0.100 |
Why?
| | Maternal Age | 1 | 2012 | 117 | 0.100 |
Why?
| | RNA-Binding Proteins | 1 | 2015 | 345 | 0.100 |
Why?
| | Acute Lung Injury | 2 | 2015 | 299 | 0.100 |
Why?
| | Catalase | 1 | 2022 | 118 | 0.100 |
Why?
| | Ubiquitin | 1 | 2022 | 57 | 0.100 |
Why?
| | Oxygen Consumption | 1 | 2014 | 588 | 0.100 |
Why?
| | Quality Control | 1 | 2022 | 144 | 0.100 |
Why?
| | Leukocytes | 1 | 2013 | 276 | 0.100 |
Why?
| | Disease Models, Animal | 4 | 2023 | 3535 | 0.100 |
Why?
| | Histones | 2 | 2022 | 535 | 0.100 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 301 | 0.100 |
Why?
| | Phosphates | 1 | 2022 | 159 | 0.100 |
Why?
| | beta 2-Microglobulin | 1 | 2011 | 45 | 0.100 |
Why?
| | Datasets as Topic | 2 | 2022 | 100 | 0.090 |
Why?
| | Transglutaminases | 1 | 2022 | 142 | 0.090 |
Why?
| | Galactosyltransferases | 1 | 2011 | 11 | 0.090 |
Why?
| | Sialyltransferases | 1 | 2011 | 13 | 0.090 |
Why?
| | HeLa Cells | 1 | 2012 | 562 | 0.090 |
Why?
| | Transfusion Reaction | 1 | 2011 | 65 | 0.090 |
Why?
| | Lipids | 2 | 2023 | 580 | 0.090 |
Why?
| | Mice, SCID | 1 | 2021 | 314 | 0.090 |
Why?
| | Linoleic Acid | 1 | 2021 | 37 | 0.090 |
Why?
| | Immunoglobulin G | 1 | 2015 | 770 | 0.090 |
Why?
| | Adenosine | 1 | 2022 | 203 | 0.090 |
Why?
| | Cell Self Renewal | 1 | 2021 | 49 | 0.090 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2006 | 134 | 0.090 |
Why?
| | HEK293 Cells | 1 | 2012 | 591 | 0.090 |
Why?
| | Risk Factors | 1 | 2023 | 8632 | 0.090 |
Why?
| | Astrocytes | 1 | 2022 | 162 | 0.090 |
Why?
| | Rabbits | 3 | 2014 | 733 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 801 | 0.090 |
Why?
| | Substrate Specificity | 1 | 2011 | 352 | 0.090 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 731 | 0.090 |
Why?
| | Phenotype | 1 | 2017 | 2797 | 0.090 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 555 | 0.080 |
Why?
| | B-Lymphocytes | 1 | 2015 | 766 | 0.080 |
Why?
| | Peptides | 1 | 2015 | 848 | 0.080 |
Why?
| | DNA Damage | 1 | 2022 | 351 | 0.080 |
Why?
| | Models, Molecular | 2 | 2020 | 1369 | 0.080 |
Why?
| | Escherichia coli | 1 | 2003 | 720 | 0.080 |
Why?
| | Phenylthiohydantoin | 1 | 2019 | 40 | 0.080 |
Why?
| | Multiple Myeloma | 1 | 2021 | 98 | 0.080 |
Why?
| | Bordetella pertussis | 1 | 2009 | 2 | 0.080 |
Why?
| | Glucosamine | 1 | 2009 | 12 | 0.080 |
Why?
| | Mitochondrial Proteins | 1 | 2011 | 219 | 0.080 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4411 | 0.080 |
Why?
| | Histone Acetyltransferases | 1 | 2019 | 51 | 0.080 |
Why?
| | Pregnancy | 3 | 2023 | 5520 | 0.080 |
Why?
| | Nitriles | 1 | 2019 | 149 | 0.080 |
Why?
| | Benzamides | 1 | 2019 | 169 | 0.080 |
Why?
| | Miller Fisher Syndrome | 1 | 2008 | 2 | 0.080 |
Why?
| | Membrane Glycoproteins | 1 | 2011 | 430 | 0.080 |
Why?
| | Guillain-Barre Syndrome | 1 | 2008 | 21 | 0.080 |
Why?
| | Multigene Family | 1 | 2009 | 190 | 0.080 |
Why?
| | DNA-Binding Proteins | 1 | 2015 | 1314 | 0.080 |
Why?
| | Critical Illness | 1 | 2013 | 646 | 0.070 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2007 | 8 | 0.070 |
Why?
| | Membrane Proteins | 2 | 2020 | 1019 | 0.070 |
Why?
| | Protein Binding | 2 | 2017 | 1890 | 0.070 |
Why?
| | Obesity | 1 | 2020 | 2508 | 0.070 |
Why?
| | Unfolded Protein Response | 1 | 2017 | 43 | 0.070 |
Why?
| | Cell Adhesion | 2 | 2020 | 432 | 0.070 |
Why?
| | Hydrolysis | 1 | 2017 | 173 | 0.070 |
Why?
| | Aged | 4 | 2021 | 19074 | 0.070 |
Why?
| | Molecular Weight | 1 | 2017 | 331 | 0.070 |
Why?
| | Carrier Proteins | 1 | 2011 | 695 | 0.070 |
Why?
| | Protein Aggregates | 1 | 2017 | 65 | 0.070 |
Why?
| | Glycine | 1 | 2007 | 152 | 0.070 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2017 | 129 | 0.070 |
Why?
| | Flow Cytometry | 3 | 2015 | 1083 | 0.070 |
Why?
| | Butyrophilins | 1 | 2016 | 5 | 0.070 |
Why?
| | Lipid Droplets | 1 | 2016 | 21 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2014 | 2765 | 0.070 |
Why?
| | Prospective Studies | 1 | 2017 | 6220 | 0.070 |
Why?
| | Cross Reactions | 2 | 2008 | 117 | 0.070 |
Why?
| | Mammary Glands, Human | 1 | 2016 | 60 | 0.070 |
Why?
| | Cytoplasm | 1 | 2016 | 255 | 0.060 |
Why?
| | Lactation | 1 | 2016 | 149 | 0.060 |
Why?
| | Monocytes | 2 | 2023 | 504 | 0.060 |
Why?
| | Methylation | 2 | 2018 | 208 | 0.060 |
Why?
| | Models, Chemical | 2 | 2006 | 248 | 0.060 |
Why?
| | Chromosome Segregation | 2 | 2015 | 36 | 0.060 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2016 | 192 | 0.060 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 15 | 0.060 |
Why?
| | 2,3-Diphosphoglycerate | 1 | 2023 | 29 | 0.060 |
Why?
| | Brain | 1 | 2015 | 2371 | 0.050 |
Why?
| | Cohort Studies | 1 | 2023 | 4895 | 0.050 |
Why?
| | Pelvic Floor | 1 | 2023 | 22 | 0.050 |
Why?
| | Kynurenine | 1 | 2024 | 81 | 0.050 |
Why?
| | Molecular Structure | 2 | 2009 | 434 | 0.050 |
Why?
| | Parturition | 1 | 2023 | 54 | 0.050 |
Why?
| | Angiopoietins | 1 | 2022 | 12 | 0.050 |
Why?
| | Thymidine | 1 | 2022 | 58 | 0.050 |
Why?
| | Pancreatic Elastase | 1 | 2022 | 66 | 0.050 |
Why?
| | Serine Proteinase Inhibitors | 1 | 2022 | 34 | 0.050 |
Why?
| | Random Allocation | 1 | 2023 | 335 | 0.050 |
Why?
| | Erythropoiesis | 1 | 2022 | 33 | 0.050 |
Why?
| | Mutation | 1 | 2022 | 3346 | 0.050 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 66 | 0.050 |
Why?
| | alpha-Globins | 1 | 2022 | 11 | 0.050 |
Why?
| | alpha 1-Antitrypsin Deficiency | 1 | 2022 | 70 | 0.050 |
Why?
| | Cell Hypoxia | 1 | 2022 | 221 | 0.050 |
Why?
| | Pentose Phosphate Pathway | 1 | 2021 | 47 | 0.050 |
Why?
| | Interleukin-8 | 1 | 2022 | 237 | 0.050 |
Why?
| | Embryo, Mammalian | 1 | 2022 | 213 | 0.050 |
Why?
| | Adolescent | 2 | 2020 | 17853 | 0.050 |
Why?
| | Chromatin | 2 | 2015 | 428 | 0.050 |
Why?
| | Membrane Microdomains | 1 | 2021 | 32 | 0.050 |
Why?
| | Least-Squares Analysis | 1 | 2021 | 70 | 0.050 |
Why?
| | Fibrosis | 1 | 2023 | 453 | 0.050 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 27 | 0.050 |
Why?
| | Access to Information | 1 | 2021 | 47 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 493 | 0.050 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 138 | 0.040 |
Why?
| | Bacteriophage lambda | 1 | 2021 | 81 | 0.040 |
Why?
| | Polymorphism, Genetic | 1 | 2023 | 610 | 0.040 |
Why?
| | Phosphorylation | 2 | 2015 | 1569 | 0.040 |
Why?
| | Fatty Acids | 1 | 2023 | 381 | 0.040 |
Why?
| | Sulfhydryl Compounds | 1 | 2022 | 177 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2020 | 1701 | 0.040 |
Why?
| | Data Mining | 1 | 2021 | 100 | 0.040 |
Why?
| | Heterozygote | 1 | 2021 | 251 | 0.040 |
Why?
| | Sperm Count | 1 | 2020 | 16 | 0.040 |
Why?
| | Sperm Motility | 1 | 2020 | 26 | 0.040 |
Why?
| | Hematopoiesis | 1 | 2021 | 171 | 0.040 |
Why?
| | Specimen Handling | 1 | 2021 | 156 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2020 | 442 | 0.040 |
Why?
| | Receptor, ErbB-2 | 1 | 2021 | 300 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2022 | 447 | 0.040 |
Why?
| | Cell Communication | 1 | 2020 | 280 | 0.040 |
Why?
| | Tissue Survival | 1 | 2018 | 13 | 0.040 |
Why?
| | Pepsin A | 1 | 2018 | 18 | 0.040 |
Why?
| | Blood Buffy Coat | 1 | 2018 | 5 | 0.040 |
Why?
| | NF-kappa B | 1 | 2022 | 641 | 0.040 |
Why?
| | Sulfates | 1 | 2018 | 43 | 0.040 |
Why?
| | DNA Methylation | 1 | 2022 | 495 | 0.040 |
Why?
| | Inpatients | 1 | 2022 | 380 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 2018 | 79 | 0.040 |
Why?
| | Filtration | 1 | 2018 | 59 | 0.040 |
Why?
| | Fluorescence | 1 | 2018 | 148 | 0.040 |
Why?
| | Complement Activation | 1 | 2021 | 340 | 0.040 |
Why?
| | Bacteriological Techniques | 1 | 2018 | 65 | 0.040 |
Why?
| | Solutions | 1 | 2018 | 146 | 0.040 |
Why?
| | Deamination | 1 | 2017 | 5 | 0.040 |
Why?
| | Calcium | 1 | 2023 | 1108 | 0.040 |
Why?
| | Genome-Wide Association Study | 1 | 2023 | 1177 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2019 | 470 | 0.040 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 20 | 0.040 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.040 |
Why?
| | Adipose Tissue | 1 | 2020 | 545 | 0.030 |
Why?
| | Bronchioles | 1 | 2016 | 22 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2380 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1448 | 0.030 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 2006 | 86 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 84 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 546 | 0.030 |
Why?
| | Amides | 1 | 2006 | 86 | 0.030 |
Why?
| | Tumor Burden | 1 | 2017 | 259 | 0.030 |
Why?
| | Chromatids | 1 | 2015 | 8 | 0.030 |
Why?
| | HMGA2 Protein | 1 | 2015 | 8 | 0.030 |
Why?
| | Mice, Nude | 1 | 2017 | 630 | 0.030 |
Why?
| | Bromodeoxyuridine | 1 | 2015 | 72 | 0.030 |
Why?
| | Chromosomes | 1 | 2015 | 85 | 0.030 |
Why?
| | Electroporation | 1 | 2015 | 31 | 0.030 |
Why?
| | Isotonic Solutions | 1 | 2015 | 39 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 433 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2017 | 217 | 0.030 |
Why?
| | Immunoglobulin Light Chains | 1 | 2015 | 36 | 0.030 |
Why?
| | Carbohydrate Conformation | 1 | 2004 | 15 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2015 | 151 | 0.030 |
Why?
| | Tranexamic Acid | 1 | 2015 | 39 | 0.030 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2015 | 72 | 0.030 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2015 | 154 | 0.030 |
Why?
| | Serologic Tests | 1 | 2004 | 49 | 0.030 |
Why?
| | Transfection | 1 | 2017 | 866 | 0.030 |
Why?
| | Seminal Plasma Proteins | 1 | 2014 | 10 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2018 | 515 | 0.030 |
Why?
| | Embryo Implantation | 1 | 2014 | 23 | 0.030 |
Why?
| | Chromosomal Instability | 1 | 2014 | 18 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 314 | 0.030 |
Why?
| | DNA Repair | 1 | 2015 | 184 | 0.030 |
Why?
| | Fetal Stem Cells | 1 | 2013 | 7 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1621 | 0.030 |
Why?
| | Fertilization in Vitro | 1 | 2014 | 71 | 0.030 |
Why?
| | Embryonic Development | 1 | 2014 | 117 | 0.030 |
Why?
| | Amino Acids | 1 | 2017 | 448 | 0.030 |
Why?
| | Species Specificity | 1 | 2004 | 542 | 0.030 |
Why?
| | Synovial Membrane | 1 | 2013 | 75 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2015 | 1016 | 0.030 |
Why?
| | Microscopy, Atomic Force | 1 | 2013 | 113 | 0.030 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2004 | 238 | 0.030 |
Why?
| | Cell Count | 1 | 2013 | 303 | 0.030 |
Why?
| | Oocyte Donation | 1 | 2012 | 4 | 0.030 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 397 | 0.030 |
Why?
| | Immunoblotting | 1 | 2003 | 283 | 0.030 |
Why?
| | Cell Movement | 1 | 2017 | 869 | 0.030 |
Why?
| | Body Mass Index | 1 | 2020 | 1959 | 0.030 |
Why?
| | Wounds, Nonpenetrating | 1 | 2015 | 256 | 0.030 |
Why?
| | Chronic Disease | 1 | 2018 | 1578 | 0.030 |
Why?
| | Hospitalization | 1 | 2021 | 1752 | 0.020 |
Why?
| | Silver Staining | 1 | 2002 | 17 | 0.020 |
Why?
| | Wnt Signaling Pathway | 1 | 2013 | 146 | 0.020 |
Why?
| | Disaccharides | 1 | 2002 | 16 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2017 | 1143 | 0.020 |
Why?
| | Cell Cycle | 1 | 2014 | 542 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2013 | 343 | 0.020 |
Why?
| | Hemodynamics | 1 | 2015 | 1012 | 0.020 |
Why?
| | Databases, Factual | 1 | 2015 | 1125 | 0.020 |
Why?
| | Antibodies | 1 | 2002 | 371 | 0.020 |
Why?
| | Gene Order | 1 | 2009 | 24 | 0.020 |
Why?
| | Glycosyltransferases | 1 | 2009 | 13 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1760 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2009 | 61 | 0.020 |
Why?
| | Gene Knockout Techniques | 1 | 2009 | 98 | 0.020 |
Why?
| | Cytokines | 1 | 2016 | 1841 | 0.020 |
Why?
| | Endopeptidase K | 1 | 2008 | 14 | 0.020 |
Why?
| | Chromatography, Thin Layer | 1 | 2008 | 24 | 0.020 |
Why?
| | Genes, Bacterial | 1 | 2009 | 157 | 0.020 |
Why?
| | Deoxyribonucleases | 1 | 2008 | 21 | 0.020 |
Why?
| | Microwaves | 1 | 2008 | 31 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2008 | 312 | 0.020 |
Why?
| | Acylation | 1 | 2007 | 28 | 0.020 |
Why?
| | Child | 1 | 2023 | 18420 | 0.010 |
Why?
|
|
Headrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|